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Abstract
Background: Integrated delivery methods in healthcare systems have been proposed to confront the increasing
complexity in general health care. INTERMED is an empirically derived, observer-rated instrument to measure case
complexity. It was intended as a visualized, action-oriented decision-support tool for the early assessment of bio-
psychosocial health risks and health needs. This study aims to document the reliability and applicability of the
Spanish version of INTERMED in liver transplant patients.
Methods: Cross-sectional study of patients who had been included in the liver transplant waiting list. Two nurses
interviewed the patients with INTERMED, and scored the instrument blind to each other. Kappa and w-kappa,
Spearman, Kendall and intraclass correlation coefficients, and Cronbach’s alfa were calculated.
Results: No patient refused the interview. Satisfactory coefficients were documented in most INTERMED items.
Kappa was = 0.858 for the categorization of patients as “complex”, and 21 of them (48.8%) were classified in this
category, and were considered to need integrated treatment.
Conclusions: The Spanish version of INTERMED is reliable. Its applicability in liver transplant patients adds to its
generalizability.
Background
Complexity in general health care is increasingly preva-
lent because of the growing number of patients who
have multi-morbid conditions, and the increased techni-
cal possibilities of medicine [1]. Furthermore, social pro-
blems [2], and particularly behavioural health disorders,
which may affect 40% or more of medical inpatients,
interfere with medical care adding up to this complexity
[3]. Social problems and mental health disorders are
usually managed independently from general somatic
disorders, and this care fragmentation has been shown
to result in medical and behavioural disorders more per-
sistent with increased complications and greater disabil-
ity, leading to higher total health care and disability
costs [3].
Integrated delivery methods in healthcare systems
have been proposed to confront the complex problems
found in present day medicine [4]. In the context of the-
oretic approaches to case complexity in the medically ill
[1], a new instrument was empirically derived,
INTERMED [5], its conceptual model being based on
observations that comprehensive understanding of
patients’ needs increases effectiveness of healthcare
delivery [6], The concept measured is case complexity
[7-9]. Specifically, INTERMED classifies information
into four domains (biological, psychological, social and
healthcare), and was intended to universally screen at
admission to medical wards, for the early identification
of patients with multiple care needs. The utility of this
method has been shown in different cultures [10] and in
different types of both ambulatory populations and in-
patients [11,12], including elderly patients [13].
INTERMED provides a quick overview of the patient’s
vulnerabilities [14], so that an integrated treatment plan
can be formulated to counteract fragmentation of medi-
cal care [3]. It also provides a model to communicate
these potential problems to the medical staff and to
facilitate an early referral [15].
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by nurses, was reported in a trauma center [7] and then
in a heterogeneous sample of patients with somatic con-
ditions [16]. The validity of this instrument has been
documented in patients admitted to internal medicine
[9], and also in specific diagnostic groups including
patients in dialysis [17], with low back pain [18], term-
inal cancer [19], diabetes [2], rheumatoid arthritis [20],
multiple sclerosis [11] and pulmonary patients [21]. It
has also been shown that compared with usual care,
nurse-led interventions based on INTERMED scores
resulted in improvements in quality of life at discharge
in a sample of general medical patients [22].
However, the applicability of INTERMED in trans-
plant patients has not been reported until now. The
early evaluation of health risks may be essential for opti-
mal care in such patients, since complexity is anticipated
in view of common medical co-morbidities and compli-
cations of medical and surgical procedures, and the fact
that they often require a life-long regimen of immuno-
suppressive medication and dependency on the trans-
plant team [23]. The burden of psychosocial problems
in transplant patients has been considered to be asso-
ciated with potential morbidity and mortality [24], and
the improvement of the accuracy and meaningfulness of
assessment, by incorporating biological, psychological,
and contextual factors that may contribute to negative
adjustment has been emphasized [25].
A Spanish version of INTERMED has been developed
[21]. However, the reliability of this version has not
been adequately documented. This is the first report
intended to document the applicability of INTERMED
in transplant patients, and the first one to document the
reliability of the Spanish version.
Methods
Setting, study design and sample
Patients who had been included in the liver transplant
waiting list of the Hospital Clinico Universitario in Zara-
goza, Spain were invited to participate by a research nurse.
The study participants were interviewed by this
research nurse and a consultation-liaison nurse, alternat-
ing the position of interviewer and observer. Following
the interview the patients were scored by both nurses,
blind to each other and using the INTERMED anchor
points. Once the scores were computed, a between-rater
consensus score for each INTERMED item was decided,
to be used in some statistical analysis.
Instrument
INTERMED is based on a review of the medical chart
and a patient semi-structured interview, which is
designed like a medical anamnesis but complemented
by psychosocial and health care-related information. It
classifies the data into the four domains related to biop-
sychosocial and health care aspects of disease, and each
domain has five variables, related to “history,”“ current
state,” and “prognoses”. The twenty resulting variables
are rated 0 to 3 [15] according to a manual with clinical
anchor points, the potential score ranging 0 to 60,
obtained by adding-up the individual variables, indicat-
ing the patient’s level of care needs [5,7].
The instrument was previously translated into Spanish
by an experienced consultation-liaison psychiatrist along
with the research nurse, and went through the forward
and backward translation process. Then, in a pilot study
among transplant patients in the same hospital, 19
patients were interviewed with INTERMED by two
trained nurses in a procedure similar to the one used in
this study. The method was considered to be feasible
and acceptable to patients, physicians and nurses. Inter-
rater agreement coefficients were in general satisfactory
(kappa >0.6), but refining the training was recom-
mended, as it has been done for this study [26].
For the present report patients were classified by
INTERMED as “complex” and “non-complex” on the
basis of the optimal cut-off score (20/21) for the need of
integrated treatment documented in previous studies
[27,21].
Statistical analysis
Inter-rater reliability was calculated for individual items
in INTERMED, as well as for the categorization of
patients as “complex” or “non-complex”. Both, kappa
and weighted-kappa (w-kappa) coefficients were used.
To further explore reliability, both Spearman and intra-
class correlation coefficients between the raters were
calculated for the INTERMED total score and the four
domain scores. Kendall’s coefficient was calculated for
the categorical variable, namely the distinction between
“complex” and “non-complex” patients. The consensus
score for each INTERMED item was used for calculating
the internal consistency of the instrument, and Cron-
bach’s alfa was applied for these calculations. As in the
original report, we further studied the structure of
INTERMED by calculating Spearman correlation coeffi-
cients among domain scores [27]. Data were analyzed
using Epidat and SPSS14.0 software.
This study was approved by the Ethical Committee
Research Comission of the Hospital Clinico Universitario.
Results
Forty three patients were assessed with INTERMED
(mean age 52.4 ± 8.7; female sex 30%). No patient
refused the interview, which was completed in an aver-
age of 20 minutes per patient.
Table 1 shows inter-rater reliability coefficients for
each INTERMED item. Satisfactory agreement was
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only observed in psychological and social prognoses,
and w-kappa values were better in almost all items.
Satisfactory agreement was also observed in the categor-
ization of patients as “complex” or “non-complex” in
INTERMED (kappa = 0.858).
Table 2 shows the mean scores by domain and mean
total scores, which were similar in both raters. Means of
the consensus scores were: biological = 7.64 (± 1.49); psy-
chological = 4.63 (± 2.41); social = 1.95 (± 1.86); health
care = 6.67 (± 1.86). Between-rater correlation coeffi-
cients for the INTERMED total score and for the four
domain scores were also quite acceptable (table 2). For
the distinction between “complex” and “non-complex”
patients Kendall’s coefficient was 0.867. Cronbach’sa l f a
coefficient for INTERMED was 0.71. Between-domain
correlations are shown in table 3. Positive correlations
are observed in general, the exception being correlations
with the social domain.
In relation to applicability of INTERMED in liver
transplant patients, 21 of them (48.8%) scored above the
cut-off score (20/21). The highest scores were observed
in the biological and health care domains, but high
scores were also given to the psychological domain
(table 2). Five (11.6%) patients scored more than one
standard deviation above the mean in the biological
domain; eight (18.6%) patients in the psychopathological
domain; ten (23.2%) patients in the social problems
domain; and the same proportion in the healthcare
domain.
Table 1 Inter-rater reliability coefficients, by INTERMED item
DOMAINS ITEMS Kappa Kappa Weighted*
Chronicity 1 1
Diagnostic dilemma 0.76 0.87
BIOLOGICAL Severity of symptoms 0.69 0.73
Diagnostic challenge 0.65 0.89
Prognosis - Complications life threat 0.86 0.87
Restrictions in coping 0.75 0.93
Psychiatric dysfunctioning 0.69 0.85
PSYCHOLOGICAL Resistance to treatment 0.61 0.69
Psychiatric symptoms 0.75 0.84
Prognosis - Mental health threat 0.42 0.31
Restrictions in integration 0.62 0.78
Social dysfunctioning 0.75 0.80
SOCIAL Residential instability 0.57 0.69
Restrictions of network 0.63 0.66
Prognosis - Social vulnerability 0.48 0.56
Intensity of treatment 0.71 0.69
Treatment experience 0.79 0.84
HEALTH CARE Organisation of care 0.83 0.91
Appropriateness of referral 1 1
Prognosis - Coordination 0.52 0.74
*Kappa weighted with quadratic wheights.
Table 2 Mean scores by INTERMED domain, mean total scores, and between-rater correlation coefficients
Domain Rater 1 Rater 2 Spearman Intraclass
Mean Min Max SD Mean Min Max SD
BIOLOGICAL
♦ 7.7 6 12 1.3 7.7 6 12 1.5 0.91* 0.92*
PSYCHOLOGICAL
♦ 4.2 0 9 2.3 4.6 1 9 2.2 0.87* 0.87*
SOCIAL
♦ 1.4 0 6 1.6 2.0 0 8 2.1 0.91* 0.76*
HEALTH CARE
♦ 6.6 3 10 1.8 6.3 3 11 1.7 0.91* 0.89*
INTERMED Score
♦♦ 19.9 13 30 4.4 20.5 12 32 4.8 0.92* 0.91*
♦Range 0-15;
♦♦Range 0-60; *p < 0.001
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One objective of this paper was to assess the reliability
of the Spanish version of INTERMED, and the overall
results were satisfactory. The raters’ agreement in the
categorization of patients as “complex” or “non-
complex” was high (k = 0.858). Similarly, inter-rater
kappa (k) coefficients were also satisfactory for most
INTERMED individual items. The measurement of
agreement is difficult, particularly when the variables of
interest have more than two possible values. However,
there is widespread consensus regarding the advantages
of the stringent kappa (k) coefficient, which takes into
account chance agreement. The main weakness of k is
that it measures the frequency of exact agreement,
rather than the degree of approximate agreement. How-
ever, to take this into account we have also calculated
weighted kappa in this particular study, the agreement
coefficients being even better. Furthermore, the reliabil-
ity of this Spanish version of INTERMED was also
supported by satisfactory Spearman and intraclass corre-
lation coefficients, when the measures were close to a
continuous distribution, namely, INTERMED total
scores and individual domain scores.
In one of the original studies, DeJonge et al reported
Spearman coefficients ranking from 0.91 to 0.96 in
assessing the different domains, and considered “very
good” the agreement in the categorization of patients as
“complex” or “non-complex, the only variable they
assessed with kappa (k = 0.85) [16]. Therefore, this
study on the Spanish version of INTERMED is in agree-
ment with and supports the results reported with the
original version.
The original authors have suggested that inexper-
ienced raters may need more training. Consequently, the
satisfactory results with the Spanish version of
INTERMED are remarkable, since one of the raters was
a research nurse without clinical experience. Moreover,
the agreement of experienced and inexperienced raters
supports the “procedural validity” of INTERMED. Proce-
dural validity speaks only of the evaluation procedure
and not to the validity of the construct itself, and is
defined as the extent to whichan e wd i a g n o s t i cp r o c e -
dure yields results similar to the results of an established
diagnostic procedure that is used as a criterion [28]. In
the absence of an established “gold standard,” the
experienced clinicians’ judgement has been used as a
comparative criterion when researchers with little clini-
cal experience are trying to use a new diagnostic instru-
ment [28,29]. It might be argued that further training
and/or refinement of items related to psychosocial prog-
nosis should be considered, since k values obtained were
below 0.5. In fact, in the first reliability study by Huyse
et al inconsistent results were reported for these items,
the agreement coefficients being low in some (ICC were
0.49 and 0.84 for the psychological prognosis; and 0.80
and 0.42 for the social prognosis; Kendall’s coefficients
were 0.52 and 0.36 for the psychological prognosis and
0.25 and 0.70 for the social prognosis) [7]. However,
that might be the closest one can come with a prognos-
tic item, since prognosis in medicine is always difficult
(with regard to any outcome) in view of the uncertain
future.
Internal consistency of the Spanish INTERMED may
also be considered to be acceptable (alfa = 0.71).
Slightly higher coefficients have been reported with the
original version of INTERMED (alfa >0.78) [27]. How-
ever, as suggested by De Jonge et al, values higher
than 0.8 can not be demanded, not even desired, in
view of the heterogeneity of domains included in
INTERMED [16]. In support of this view, between-
domain correlations were statistically significant, but
modest (Sperman’s around 0.3), and the correlations
with the social domain were non-significant. In fact,
common clinical sense does not require in liver
transplant patients that, for example, the severity of
the biological condition should have a proportional
counterpart of social problems.
In relation to applicability, the second objective in this
report, no patient refused the interview. It is noticeable
that nurses, even with limited clinical experience in
patient care were able to detect in a 20 minutes inter-
view, early after inclusion of patients in the transplant
waiting list, that almost half of them had high levels of
potential complexity. “Complex” patients in INTERMED
have been considered to need integrated treatment [30].
The needs of psycho-social attention in this particular
sample are supported by the proportion of patients scor-
ing above the 20/21 threshold point proposed (48.8%).
Previous studies have also shown considerable propor-
tions of complex patients according to the same
INTERMED criteria: 62.3% among diabetic patients [2]
and 12.8% or 21.4 (%) among multiple sclerosis patients
[11]. Physicians are well prepared to detect the severity
of the medical condition, but under-detection of psycho-
pathological and social problems is common in medi-
cine and has been associated with negative outcomes
[3]. Specifically, psychopathological problems in
liver transplant patients have been considered to be
Table 3 Spearman correlations among INTERMED domain
scores
BIOLOGICAL PSYCHOLOGICAL SOCIAL
Spearman Spearman Spearman
PSYCHOLOGICAL 0.32* - -
SOCIAL 0.05 0.08 -
HEALTH CARE 0.28 0.38* 0.24
*p < 0.05
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evaluation and then the appropriate management of
complex transplant recipients might be essential for
optimal patient care [23].
Fragmentation of care into biological, psychopathoplo-
gical and social care may be even more detrimental in
liver transplant patients than in other, less complex
medical patients [3]. The early detection with an instru-
ment such as INTERMED, intended to enhance the
communication between patients and the health provi-
ders as well as between different professions and disci-
plines [31] should facilitate the early development of
individualized, integral care planning. Coordination
between professionals, which may also be facilitated by
the use of INTERMED, has been suggested to affect
patients’ clinical outcomes and satisfaction with their
care [32,33]. Efforts have been done to improve health
service utilization and costs with new models of guided,
comprehensive healthcare provided for people with
complex health conditions [34,35]. There is some evi-
dence of improved health outcomes following an inter-
vention targeted for complex medical patients identified
by INTERMED [36].
In support of the applicability of the use of
INTERMED, this study was completed in a socio-cul-
tural environment different from most previous studies.
Patients in this sample were recruited in a rather typical
public hospital in Spain, which covers a geographical
health area and populations with a wide range of socio-
economical background. Therefore, the results support
its future use in Spanish speaking populations.
Conclusions
The Spanish version of INTERMED is reliable. More-
over, since the validity of this instrument was previously
documented in different types of medical patients, this
study adds to the applicability of INTERMED in special
populations such as the liver transplant patients, with
high levels of complexity as shown in this study. The
usefulness of INTERMED in studies such as the ongoing
multi-national, European study in liver transplant
patients [37] is now further supported. However, its uti-
lity in improving health care delivery for complex liver
transplant still needs to be evaluated.
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